Healthcare >> CEO Interviews >> March 17, 2009
CHIP JACOB is founding CEO and Director of Calcionics Corporation. Prior to
Calcionics, Mr. Jacob co-founded and led Sangretech Biomedical LLC, where he
took the company's cell therapy targeting solid tumor cancers through proof-of-
concept and out-licensed the technology to an industry leader. Mr. Jacob was
previously employed in a number of positions of increasing responsibility in
business development and project management at Northwest Biotherapeutics, Inc.
He founded and later sold his first company, Electra Inc., a computer hardware
and software distributor, before embarking on his career in biotechnology. Mr.
Jacob holds an MBA from the University of Washington. Profile
TWST: We'd like to begin with a brief historical sketch of the company and a picture of the things you're doing right now.
Mr. Jacob: Calcionics was formed in 2007 with initial technology